<em>LASS2</em> overexpression enhances early apoptosis of lung cancer cells through the caspase‑dependent pathway

Wang,Yamei; Li,Shirong; Weng,Lixin; Du,Hua; Wang,Jingyuan; Xu,Xiaoyan

doi:10.3892/or.2022.8435

LASS2 overexpression enhances early apoptosis of lung cancer cells through the caspase‑dependent pathway

Authors:
- Yamei Wang
- Shirong Li
- Lixin Weng
- Hua Du
- Jingyuan Wang
- Xiaoyan Xu
View Affiliations

Affiliations: Department of Pathology, College of Basic Medical Sciences, Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region 010059, P.R. China
Published online on: October 25, 2022 https://doi.org/10.3892/or.2022.8435
Article Number: 220

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In a previous study by the authors, the longevity assurance homolog 2 (LASS2) gene was determined to inhibit activity of vacuolar H⁺‑ATPase (V‑ATPase) by combining with the C subunit (ATP6L) of V‑ATPase. However, the influence of LASS2 overexpression and silencing on apoptosis of human lung cancer cells 95D or 95C remains unclear. Thus, the effect of LASS2 on apoptosis and its potential mechanisms were investigated in 95D and 95C cells. Using the lentiviral transfection method, lentiviral vectors of LASS2 overexpression and silencing were transfected into 95D and 95C cells, respectively. The apoptotic ability of tumor cells was observed by flow cytometry. The expression levels of LASS2, Bcl‑2, Bax, cytochrome c, caspase‑9, and caspase‑3 were detected by western blotting. CCK‑8 assay was used to detect the growth ability of tumor cells in vitro. Flow cytometric analysis revealed that LASS2 overexpression could promote the early apoptosis of lung cancer cells 95D. CCK‑8 assay demonstrated that LASS2 overexpression inhibited the proliferation of 95D cells. Additionally, LASS2 overexpression decreased the expression of Bcl‑2, induced the release of cytochrome c from mitochondria, and promoted the activation of caspase‑9 and caspase‑3. There was a significant difference in the expression of Bcl‑2, cytochrome c, caspase‑9 and caspase‑3 in the LASS2‑overexpression group compared with the normal and negative control groups. Alternatively, the aforementioned experiments in lung cancer cells 95C following LASS2 silencing produced the opposite effects. LASS2 may induce early apoptosis of lung cancer cells by influencing the caspase‑dependent mitochondrial pathway.

View Figures

View References

1	Gerard IE and Karen HV: Proliferation, cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001. View Article : Google Scholar : PubMed/NCBI
2	Mcconkey BJ, Bold RJ and Termuhlen PM: Apoptosis, cancer and cancer therapy. Surg Oncol. 6:133–142. 1997. View Article : Google Scholar : PubMed/NCBI
3	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
4	Ma C, Liu Y, Zheng J, Fang W, You J, Wang J, Cui X and Wu B: Identification of tumor metastasisrelated gene TMSG-1 by mRNA differential display. Sci China C Life Sci. 45:553–560. 2002. View Article : Google Scholar : PubMed/NCBI
5	Pan H, Qin WX, Huo KK, Wan DF, Yu Y, Xu ZG, Hu QD, Gu KT, Zhou XM, Jiang HQ, et al: Cloning, mapping, and characterization of a human homologue of the yeast longevity assurance gene LAG1. Genomics. 77:58–64. 2001. View Article : Google Scholar : PubMed/NCBI
6	Xu XY, Pei F and You JF: TMSG-1 and its roles in tumor biology. Chin J Cancer. 29:697–702. 2010. View Article : Google Scholar : PubMed/NCBI
7	Yu W, Wang L, Wang Y, Xu X, Zou P, Gong M, Zheng J, You J, Wang H, Mei F and Pei F: A novel tumor metastasis suppressor gene LASS2/TMSG1 interacts with vacuolar ATPase through its homeodomain. J Cell Biochem. 114:570–583. 2013. View Article : Google Scholar : PubMed/NCBI
8	Teufel A, Maass T, Galle PR and Malik N: The longevity assurance homologue of yeast lag1 (Lass) gene family (review). Int J Mol Med. 23:135–140. 2009.PubMed/NCBI
9	Xu X, You J and Pei F: LASS2/TMSG1 gene silencing promotes the invasiveness and metastatic of human prostatic carcinoma cells through increase in vacuolar ATPase activity. Zhonghua Bing Li Xue Za Zhi. 43:177–183. 2014.(In Chinese). PubMed/NCBI
10	Fan S, Niu Y, Tan N, Wu Z, Wang Y, You H, Ke R, Song J, Shen Q, Wang W, et al: LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump. Oncogene. 32:1682–1690. 2013. View Article : Google Scholar : PubMed/NCBI
11	Chen L, Lu X, Zeng T, Chen Y, Chen Q, Wu W, Yan X, Cai H, Zhang Z, Shao Q and Qin W: Enhancement of DEN-induced liver tumourigenesis in hepatocyte-specific Lass2-knockout mice coincident with upregulation of the TGF-β1-Smad4-PAI-1 axis. Oncol Rep. 31:885–893. 2014. View Article : Google Scholar : PubMed/NCBI
12	Wang B: Expression and clinical significance of TMSG1 in gastric cancer. China Practical Medicine. 8:1–2. 2013.
13	Yang Y, Yang X, Li L, Yang G, Ouyang X, Xiang J, Zhang T and Min X: LASS2 inhibits proliferation and induces apoptosis in HepG2 cells by affecting mitochondrial dynamics, the cell cycle and the nuclear factor-κB pathways. Oncol Rep. 41:3005–3014. 2019.PubMed/NCBI
14	Tingqi Z, Shirong L and Jingyuan W: Expression of LASS2/TMSG1 in non small cell lung cancer and its clinical significance. J Clin Exp Pathol. 36:323–325. 2020.
15	Haiqin X, Shirong L, Lixin W, Jingyuan W, Hai L and Xiaoyan X: Expression and significance of LASS2/TMSG-1 in human lung cancer cell lines with different metastatic potentiality. Journal of Shanxi Medical University. 047:884–889. 2016.
16	Xu Haiqin LS, Weng Lixin, Wang Jingyuan, Hai Ling and Xu Xiaoyan: Expression and significance of LASS2 /TMSG-1 in human lung cancer cell lines with different metastatic potentiality. J Shanxi Med Univ. 47:884–889. 2016.
17	Chen SH, Bubb MR, Yarmola EG, Zuo J, Jiang J, Lee BS, Lu M, Gluck SL, Hurst IR and Holliday LS: Vacuolar H+-ATPase binding to microfilaments: Regulation in response to phosphatidylinositol 3-kinase activity and detailed characterization of the actin-binding site in subunit B. J Biol Chem. 279:7988–7998. 2004. View Article : Google Scholar : PubMed/NCBI
18	Su J, You J, Zhen J, Cui X and Fang W: Studies of tumor metastasis suppressor gene TMSG-1 inhibited proliferation and invasion of prostate cancer cell line PC-3M-1E8 in vitro. Zhonghua Zhong Liu Za Zhi. 30:404–407. 2008.(In Chinese). PubMed/NCBI
19	Tang N, You H, Jin J, Yu B and Qin W: Small interfering RNA targeting LASS2 gene enhances invasion capacity of hepatocellular carcinoma cells. Tumor. 29:399–403. 2009.
20	Mehlen P and Puisieux A: Metastasis: A question of life or death. Nat Rev Cancer. 6:449–458. 2006. View Article : Google Scholar : PubMed/NCBI
21	Wong NC, Mueller BM, Barbas CF, Ruminski P, Quaranta V, Lin EC and Smith JW: Alphav integrins mediate adhesion and migration of breast carcinoma cell lines. Clin Exp Metastasis. 16:50–61. 1998. View Article : Google Scholar : PubMed/NCBI
22	Townson JL, Naumov GN and Chambers AF: The role of apoptosis in tumor progression and metastasis. Curr Mol Med. 3:631–642. 2003. View Article : Google Scholar : PubMed/NCBI
23	Márquez-Jurado S, Díaz-Colunga J, das Neves RP, Martinez-Lorente A, Almazán F, Guantes R and Iborra FJ: Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression. Nat Commun. 9:3892018. View Article : Google Scholar : PubMed/NCBI
24	Zou P, Yang Y, Xu X, Liu B, Mei F, You J, Liu Q and Pei F: Silencing of vacuolar ATPase c subunit ATP6V0C inhibits the invasion of prostate cancer cells through a LASS2/TMSG1-independent manner. Oncol Rep. 39:298–306. 2018.PubMed/NCBI
25	Wang H, Zuo Y, Ding M, Ke C, Yan R, Zhan H, Liu J, Wang W, Li N and Wang J: LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity. Oncol Lett. 13:661–668. 2017. View Article : Google Scholar : PubMed/NCBI
26	Xu X YR, Li X, Yu H and Li S: Effect of LASS2/TMSG-1 overexpression on the invasion and migration of 95D human pulmonary carcinoma cell and its mechanism. Chinese Journal of Clinical and Experimental Pathology. 32:901–907. 2016.
27	Zuo H LX, Li S, Yun F and Xu X: Effect of LASS2/TMSG on the invation and migration of 95C human pulmonary carcinoma cell. Chinese Journal of Cancer Prevention and Treatment. 22:1865–1873. 2015.
28	Zeng F, Huang L, Cheng X, Yang X, Li T, Feng G, Tang Y and Yang Y: Overexpression of LASS2 inhibits proliferation and causes G0/G1 cell cycle arrest in papillary thyroid cancer. Cancer Cell Int. 18:1512018. View Article : Google Scholar : PubMed/NCBI
29	Beyenbach KW and Wieczorek H: The V-type H+ ATPase: Molecular structure and function, physiological roles and regulation. J Exp Biol. 209:577–589. 2006. View Article : Google Scholar : PubMed/NCBI
30	De Milito A, Canese R, Marino ML, Borghi M, Iero M, Villa A, Venturi G, Lozupone F, Iessi E, Logozzi M, et al: pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer. 127:207–219. 2010. View Article : Google Scholar : PubMed/NCBI
31	Kumar S, Kasseckert S, Kostin S, Abdallah Y, Schafer C, Kaminski A, Reusch HP, Piper HM, Steinhoff G and Ladilov Y: Ischemic acidosis causes apoptosis in coronary endothelial cells through activation of caspase-12. Cardiovasc Res. 73:172–180. 2007. View Article : Google Scholar : PubMed/NCBI
32	Yang T, Li MH, Liu J, Huang N, Li N, Liu SN, Liu Y, Zhang T, Zou Q and Li H: Benzimidazole derivative, BMT-1, induces apoptosis in multiple myeloma cells via a mitochondrial-mediated pathway involving H+/K+-ATPase inhibition. Oncol Rep. 31:2743–2750. 2014. View Article : Google Scholar : PubMed/NCBI
33	Bock FJ and Tait SW: Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 21:85–100. 2019. View Article : Google Scholar : PubMed/NCBI
34	Chen M and Wang J: Initiator caspases in apoptosis signaling pathways. Apoptosis. 7:313–319. 2002. View Article : Google Scholar : PubMed/NCBI
35	Rosse T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B and Borner C: Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature. 391:496–499. 1998. View Article : Google Scholar : PubMed/NCBI
36	Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:609–619. 1993. View Article : Google Scholar : PubMed/NCBI
37	Huang S, He P, Xu D, Li J, Peng X and Tang Y: Acidic stress induces apoptosis and inhibits angiogenesis in human bone marrow-derived endothelial progenitor cells. Oncol Lett. 14:5695–5702. 2017.PubMed/NCBI
38	Sasazawa Y, Futamura Y, Tashiro E and Imoto M: Vacuolar H+-ATPase inhibitors overcome Bcl-xL-mediated chemoresistance through restoration of a caspase-independent apoptotic pathway. Cancer Sci. 100:1460–1467. 2009. View Article : Google Scholar : PubMed/NCBI
39	Pérez-Pérez A, Toro A, Vilariño-Garcia T, Guadix P, Maymó J, Dueñas JL, Varone C and Sánchez-Margalet V: Leptin protects placental cells from apoptosis induced by acidic stress. Cell Tissue Res. 375:733–742. 2019. View Article : Google Scholar : PubMed/NCBI
40	Fujiwara M, Tian L, Le PT, DeMambro VE, Becker KA, Rosen CJ and Guntur AR: The mitophagy receptor Bcl-2-like protein 13 stimulates adipogenesis by regulating mitochondrial oxidative phosphorylation and apoptosis in mice. J Biol Chem. 294:12683–12694. 2019. View Article : Google Scholar : PubMed/NCBI
41	Edlich F: BCL-2 proteins and apoptosis: Recent insights and unknowns. Biochem Biophy Res Commun. 500:26–34. 2018. View Article : Google Scholar : PubMed/NCBI
42	Wallberg F, Tenev T and Meier P: Analysis of apoptosis and necroptosis by fluorescence-activated cell sorting. Cold Spring Harbor Protoc 1. pdb.prot087387. 2016. View Article : Google Scholar : PubMed/NCBI